Regeneron Pharmaceuticals, Inc’s recently made public that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.84 million on Nov 01 ’24. In the deal valued at $844.61 per share,1,000 shares were sold. As a result of this transaction, McCourt Marion now holds 12,931 shares worth roughly $9.79 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MARION E MCCOURT bought 1,000 shares, generating $844,610 in total proceeds.
Before that, RYAN ARTHUR F sold 100 shares. Regeneron Pharmaceuticals, Inc shares valued at $104,878 were divested by the Director at a price of $1048.78 per share. As a result of the transaction, RYAN ARTHUR F now holds 17,582 shares, worth roughly $13.31 million.
Wolfe Research initiated its Regeneron Pharmaceuticals, Inc [REGN] rating to an Outperform in a research note published on November 15, 2024; the price target was $1150. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in mid November with a ‘”a Neutral”‘ rating. Leerink Partners also remained covering REGN and has decreased its forecast on September 24, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Bernstein started covering the stock on March 12, 2024. It rated REGN as “an Outperform”.
Price Performance Review of REGN
On Friday, Regeneron Pharmaceuticals, Inc [NASDAQ:REGN] saw its stock fall -3.28% to $756.81. Over the last five days, the stock has lost -8.64%. Regeneron Pharmaceuticals, Inc shares have fallen nearly -13.83% since the year began. Nevertheless, the stocks have fallen -4.49% over the past one year. While a 52-week high of $1211.20 was reached on 08/27/24, a 52-week low of $780.95 was recorded on 11/15/24. SMA at 50 days reached $985.21, while 200 days put it at $1,006.47.
Levels Of Support And Resistance For REGN Stock
The 24-hour chart illustrates a support level at 745.97, which if violated will result in even more drops to 735.12. On the upside, there is a resistance level at 775.38. A further resistance level may holdings at 793.94. The Relative Strength Index (RSI) on the 14-day chart is 11.99, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -50.93, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.29%. Stochastics %K at 1.13% indicates the stock is a buying.
How much short interest is there in Regeneron Pharmaceuticals, Inc?
A steep rise in short interest was recorded in Regeneron Pharmaceuticals, Inc stocks on 2024-10-31, growing by 0.12 million shares to a total of 1.85 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.73 million shares. There was a rise of 6.53%, which implies that there is a positive sentiment for the stock.
